Nancy Pronsati, vice president of the board of ALK Positive, began her journey in 2014 after multiple misdiagnoses of chronic bronchitis and a persistent cough, which were later identified as stage 4 ALK-positive lung cancer.
After years of chronic cough and misdiagnosed infections, a 2016 stage 4 ALK-positive lung cancer diagnosis led to targeted therapy that has helped since.